Thewarach Laha Selected Research

Opisthorchiasis

7/2021	Monoclonal Antibodies Targeting an Opisthorchis viverrini Extracellular Vesicle Tetraspanin Protect Hamsters against Challenge Infection.
5/2021	Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.
4/2020	Partial protection with a chimeric tetraspanin-leucine aminopeptidase subunit vaccine against Opisthorchis viverrini infection in hamsters.
4/2020	Effects of Opisthorchis viverrini infection on glucose and lipid profiles in human hosts: A cross-sectional and prospective follow-up study from Thailand.
12/2019	Recombinant Opisthorchis viverrini tetraspanin expressed in Pichia pastoris as a potential vaccine candidate for opisthorchiasis.
9/2018	Granulin Expression in Hamsters during Opisthorchis viverrini Infection-Induced Cholangiocarcinogenesis
8/2017	Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
8/2017	Chicken IgY-based coproantigen capture ELISA for diagnosis of human opisthorchiasis.
12/2015	Immunodiagnosis of opisthorchiasis using parasite cathepsin F.
8/2015	Apoptosis of cholangiocytes modulated by thioredoxin of carcinogenic liver fluke.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thewarach Laha Research Topics

Disease

28	Infections 01/2022 - 03/2008
20	Opisthorchiasis 07/2021 - 11/2008
13	Cholangiocarcinoma 01/2020 - 05/2007
9	Neoplasms (Cancer) 09/2018 - 06/2007
8	Fibrosis (Cirrhosis) 05/2021 - 10/2009
7	Inflammation (Inflammations) 01/2017 - 05/2007
4	Schistosomiasis (Bilharziasis) 11/2021 - 03/2010
2	Bile Duct Neoplasms (Bile Duct Cancer) 01/2021 - 01/2012
2	Colitis 01/2017 - 06/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017 - 06/2013
2	Wounds and Injuries (Trauma) 11/2015 - 10/2015
2	Carcinogenesis 08/2015 - 06/2007
1	Schistosomiasis haematobia (Schistosomiasis haematobium) 11/2021
1	Strongyloidiasis 06/2021
1	Body Weight (Weight, Body) 01/2021
1	Digestive System Diseases 01/2018
1	Dust Mite Allergy 10/2016
1	Asthma (Bronchial Asthma) 10/2016
1	Glomerulonephritis 01/2013
1	Disease Progression 10/2012
1	Persistent Infection 10/2012
1	Chronic Disease (Chronic Diseases) 01/2012
1	Cysts 03/2008

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2019 - 06/2007
8	VaccinesIBA 01/2021 - 03/2010
7	TetraspaninsIBA 01/2022 - 01/2012
6	EnzymesIBA 06/2021 - 11/2008
5	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2012
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 10/2009
4	AntibodiesIBA 11/2021 - 11/2008
4	AntigensIBA 11/2021 - 03/2010
4	GranulinsIBA 01/2020 - 10/2015
4	CarcinogensIBA 01/2012 - 05/2007
3	Subunit VaccinesIBA 01/2022 - 04/2020
3	ImmunosorbentsIBA 06/2021 - 03/2012
3	Immunoglobulin G (IgG)IBA 06/2021 - 03/2012
3	Interleukin-6 (Interleukin 6)IBA 11/2015 - 10/2009
3	Peptide Hydrolases (Proteases)FDA Link 06/2013 - 03/2010
2	Monoclonal AntibodiesIBA 07/2021 - 12/2013
2	Praziquantel (Biltricide)FDA Link 05/2021 - 08/2017
2	Cathepsin FIBA 08/2017 - 12/2015
2	IgYIBA 08/2017 - 12/2015
2	Cysteine Proteases (Cysteine Protease)IBA 12/2015 - 03/2008
2	Oxidoreductases (Dehydrogenase)IBA 08/2015 - 01/2015
2	ethyl acetateIBA 12/2013 - 03/2012
2	Formaldehyde (Formol)FDA Link 12/2013 - 03/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012 - 08/2008
2	AnnexinsIBA 10/2011 - 03/2010
1	MutagensIBA 01/2021
1	Ethyl MethanesulfonateIBA 01/2021
1	LipidsIBA 04/2020
1	Glucose (Dextrose)FDA LinkGeneric 04/2020
1	Leucyl Aminopeptidase (Peptidase S)IBA 04/2020
1	ProgranulinsIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2018
1	DNA AdductsIBA 01/2017
1	Dextran SulfateIBA 01/2017
1	ProteomeIBA 01/2017
1	OxysterolsIBA 01/2017
1	Bile Pigments (Bilin)IBA 01/2017
1	MucinsIBA 01/2017
1	Recombinant ProteinsIBA 10/2016
1	ThioredoxinsIBA 08/2015
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2015
1	RNA (Ribonucleic Acid)IBA 03/2014
1	Pharmaceutical PreparationsIBA 12/2013
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 06/2013
1	Interleukin-4 (Interleukin 4)IBA 06/2013
1	human oval cell antigenIBA 01/2013
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2013
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2012
1	CalciumIBA 03/2012
1	CathepsinsIBA 03/2012
1	Cathepsin BIBA 03/2012
1	NickelIBA 03/2012
1	Indicators and Reagents (Reagents)IBA 03/2012
1	PeroxiredoxinsIBA 03/2012
1	A 19IBA 01/2012
1	InterleukinsIBA 01/2012
1	CytokinesIBA 10/2011
1	NitrosaminesIBA 05/2011
1	Extracellular Matrix ProteinsIBA 06/2010
1	Apoptosis Regulatory ProteinsIBA 03/2010
1	Complex MixturesIBA 03/2010
1	Cathepsin LIBA 03/2008
1	HydrolasesIBA 03/2008

Therapy/Procedure

2	Therapeutics 07/2021 - 06/2013
1	Aftercare (After-Treatment) 01/2017
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2012